Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.30
Bid: 36.30
Ask: 37.00
Change: 0.525 (1.45%)
Spread: 0.70 (1.928%)
Open: 35.80
High: 36.30
Low: 35.80
Prev. Close: 36.125
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: H&T Group, China Medical, Fyffes...

Wed, 13th May 2009 09:20

Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for the current year but remains conscious of the current difficult economic climate."The principal reason for the strong performance is the sustained gold price which has benefitted the Group's retail sales, auctions, scrap and gold purchases. The Group is also pleased with the continuing success of the store expansion programme," said H&T.Chinese pharmaceutical sales, marketing & research firm China Medical saw pre-tax profit rise to $19.5m from $10.3m before on sales 40% to $72.6m. Total dividend for year will be $0.15p share against $0.10p each. "I am delighted to report on a second outstanding year for CMS as a public company despite the challenging economic environment seen domestically and globally. We have achieved sustained and steady growth in sales and profits, and I am pleased that," said the group.Fruit importer and distributor Fyffes said trading in teh year to date has been in line with expectations and it remains on course to achieve its earnings target for the year. Previously it has taargeted an adjusted EVIB for 2009 in the range of €14m-€18m. Shares in Futura Medical fell back after the consumer healthcare products firm reported a delay in achieving regulatory approval for CSD500, a condom designed to help men maintain an erection.Futura, which is developing the condom with Durex firm SSL, hoped the product would be awarded a CE mark soon after EU authorities expressed a positive opinion on the product's pharmaceutical aspects. However, SSL's decision to move condom manufacturing to Asia means the EU has asked for additional manufacturing data on CSD500 and Futura now expects to receive CE marketing authorisation around the end of the year.Public sector focused support services company Tribal said trading in 2009 has been in line with expectations.The sales pipeline remains healthy while committed income now stands at £210m, up from £139m at the beginning of the year. Printing group Communisis shot up after it announced a contract to T-Mobile UK 's marketing division with a suite of printing services. The contract was awarded to Communisis following a tender process. Housebuilder McInerney said trading conditions during 2009 in its key markets of Ireland and UK continue to be challenging due to low consumer confidence, restricted access to mortgages and the uncertain financial climate."We remain focused on generating positive cash flow and the implementation of additional efficiencies in the Group's cost base. Management's key objective is to rebuild shareholder value in the medium term," it said.Shares in Rheochem slipped back down again today after the oil and gas firm released a statement saying it knew of no reason behind its sudden share price rise earlier in the day. The group said the strategic review of its oil and gas assets are still ongoing and no decision has been reached.
More News
10 Aug 2020 11:30

IN BRIEF: Positive QMS Opinion For Futura Medical's MED3000

IN BRIEF: Positive QMS Opinion For Futura Medical's MED3000

Read more
4 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Read more
4 Aug 2020 12:57

Futura Medical upbeat on cannabidiol gel lab work

(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of initial laboratory and optimisation work on a 'Dermasys' cannabidiol gel, dubbed 'CBD100', under the joint venture collaboration agreement with CBDerma Technology that was announced in September.

Read more
14 Jul 2020 21:51

IN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation

IN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation

Read more
24 Jun 2020 11:45

Futura Medical Reports Limited Impact Of Covid-19 On Its Operations

Futura Medical Reports Limited Impact Of Covid-19 On Its Operations

Read more
24 Jun 2020 11:06

Futura makes good progress with topical erectile dysfunction treatment

(Sharecast News) - Futura Medical updated the market on Wednesday, reporting that the impact of the Covid-19 pandemic on the company had been "limited" to date.

Read more
18 Jun 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2020 09:45

UK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight

UK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight

Read more
20 Apr 2020 16:09

Futura files for second FDA meeting over erection gel

(Sharecast News) - Futura Medical has filed for a further pre-submission meeting with the US Food and Drug Administration (FDA), it announced on Monday, following receipt of the complete and signed clinical study report for its phase 3 Study, 'FM57'.

Read more
20 Apr 2020 13:24

Futura Files For Erectile Dysfunction Treatment Pre-Submission Meeting

Futura Files For Erectile Dysfunction Treatment Pre-Submission Meeting

Read more
1 Apr 2020 11:10

Futura Optimistic Over Approvals For Erectile Dysfunction Treatment

Futura Optimistic Over Approvals For Erectile Dysfunction Treatment

Read more
25 Mar 2020 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
13 Feb 2020 18:33

Futura Pursues Regulatory Approval For Erectile Dysfunction Treatment

Futura Pursues Regulatory Approval For Erectile Dysfunction Treatment

Read more
10 Jan 2020 16:10

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
23 Dec 2019 09:53

Futura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier

Futura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.